Jan 10, 2024 / 11:45PM GMT
Rachel Vatnsdal JPMorgan Chase&Co.-Analyst
Perfect. Good afternoon, everyone. This is Rachel Vatnsdal with the life science tools and diagnostics team at JPMorgan. I'm joined today with the Akoya Biosciences management team up here. And so if any of you in the room do have questions, please feel free to send them to me directly or you can submit them via portal. With that, I will ask Brian to kick us off with the presentation.
Brian McKelligon - Akoya Biosciences Inc - President, Chief Executive Officer, Director
Thank you, Rachel. On behalf of all my colleagues at Akoya, thanks to you and your team at JPMorgan for having us. So again, I'm Brian McKelligon, the CEO of Akoya. Maybe just before I get started, I think Akoya, I think we're both proud and humbled by the journey over the last five or six years. Proud in that we've taken a handful of people and this idea of spatial biology and turned it into a company that's going to deliver just under $100 million this year. But really humbled because we feel like we have some distance to
Akoya Biosciences Inc at JPMorgan Healthcare Conference Transcript
Jan 11, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers